Home / Benchmarks / Medical Practice Specialty
Medical Practice Specialty Valuation Multiples (2026)
EBITDA & revenue sale multiples, deal flow, and active acquirers - based on 235real disclosed M&A transactions in the medical practice specialty space. Run the calculator below to price your business at current multiples.
What multiple does a medical specialty sell for?
In the $5M-$25M EV range, a medical specialty sold at a median of 5.9x EBITDA (middle 50% of deals 5.1x-8.2x) across 15disclosed M&A transactions, 2018-2026, from SEC EDGAR filings and verified press releases. That is the population midpoint — your specific number depends on margins, growth, customer concentration, and owner-dependence.
Updated 2026-07-31 · 15 disclosed deals · source window 2018-2026
| Size bracket | Median EV/EBITDA | Typical range (IQR) | n |
|---|---|---|---|
| $5M-$25M EV | 5.9x | 5.1x-8.2x | 15 |
Aggregate population median for the size bracket - disclosed transactions only (SEC EDGAR + verified press releases), 2018-2026, n≥10 per cell. A precise figure for your business depends on margins, growth, customer concentration, and owner-dependence. See the full $5M-$25M EV breakdown →
Tracking the medical specialty market? Get a free email alert when a medical specialty business sells — the deal, the buyer, and the multiple it went for.
CPA, attorney, or advisor? Put this data on your own site — free embeddable multiples widget and calculator.
State of Medical SpecialtyM&A in 2026
The medical practice specialty M&A market is tracked across 235 disclosed transactions in the ExitValue.ai database (147 with EBITDA disclosed, 202 with revenue). The current market trend is consolidating.
Active acquirers include Cencora, Inc., ClinActiv Holdings Inc., Hartford HealthCare, Cardinal Health. Recent named transactions: EyeSouth Partners' Retina Business (2026); Crescita Therapeutics Inc. (2026); Consulting Cardiologists (2026).
Premium valuations in medical specialty are driven by procedural revenue mix vs e&m-heavy (procedures trade 2-3 turns higher on ebitda); asc ownership stake or in-office ancillary (imaging / lab / infusion) as second income leg; multi-physician partnership with associate pipeline (proves transferability to pe / strategic).
What compresses valuations: solo practitioner with no associates (kills dso / pe buyer pool entirely); single-payer contract above 40% with non-portability clause (multiple compresses 25%+); narrow geographic catchment area (limits scale story for any consolidator buyer).
Source: SEC filings, EDGAR 8-K/S-4, and verified press releases. Run the calculator below to see the specific multiples that apply to your business.
Recent named M&A deals in medical specialty
Most-recent disclosed transactions. Click any deal for full detail (multiples, financials, source).
Sourced from SEC filings, EDGAR 8-K/S-4, and verified press releases.
Get an instant valuation for your medical specialty
Backed by the same 235 disclosed transactions, adjusted for your specific size and margin.
Get your full valuation analysis
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
What drives a premium valuation
- ●Procedural revenue mix vs E&M-heavy (procedures trade 2-3 turns higher on EBITDA)
- ●ASC ownership stake or in-office ancillary (imaging / lab / infusion) as second income leg
- ●Multi-physician partnership with associate pipeline (proves transferability to PE / strategic)
What compresses valuation
- ●Solo practitioner with no associates (kills DSO / PE buyer pool entirely)
- ●Single-payer contract above 40% with non-portability clause (multiple compresses 25%+)
- ●Narrow geographic catchment area (limits scale story for any consolidator buyer)
Medical Specialty valuation: common questions
What multiple does a medical specialty sell for?
In the $5M-$25M EV range, a medical specialty sold at a median of 5.9x EBITDA (middle 50% of deals 5.1x-8.2x) across 15 disclosed M&A transactions filed 2018-2026 (SEC EDGAR + verified press releases). That is the aggregate population midpoint for the size bracket; a precise figure for your specific business depends on margins, growth, customer concentration, and owner-dependence — run the ExitValue.ai medical specialty calculator for that.
How is a medical specialty business valued?
Medical Practice Specialty businesses are valued by benchmarking against comparable completed M&A transactions, then adjusting for the specific business. Owner-operator practices are typically priced on an earnings or seller-discretionary-earnings basis, while businesses at platform scale shift toward institutional earnings-multiple methodology. The ExitValue.ai engine selects the methodology that the comparable deal set actually used and adjusts for margin quality, growth, owner dependency, customer concentration, and recurring-revenue mix.
What drives medical practice specialty valuation?
The biggest value levers in medical practice specialty are recurring or repeat revenue, owner independence (the business runs without the founder), customer diversification (no single client dominates), a credible growth trajectory, and operating-margin quality relative to the vertical. In this space specifically, buyers pay up for procedural revenue mix vs e&m-heavy (procedures trade 2-3 turns higher on ebitda); asc ownership stake or in-office ancillary (imaging / lab / infusion) as second income leg; multi-physician partnership with associate pipeline (proves transferability to pe / strategic).
How many medical practice specialty M&A deals are tracked?
ExitValue.ai tracks 235 disclosed medical practice specialty M&A transactions, 147 with EBITDA disclosed, 202 with revenue disclosed, sourced from SEC filings, EDGAR 8-K/S-4 documents, and verified press releases and refreshed daily. Current market trend: consolidating.
Who buys medical practice specialty businesses?
Medical Practice Specialty businesses are acquired by strategic acquirers (larger operators in the same space), and private-equity platforms and roll-up consolidators, and unknown. Recent named acquirers include Cencora, Inc., ClinActiv Holdings Inc., Hartford HealthCare, Cardinal Health.
What is my medical specialty business worth?
Run the ExitValue.ai medical specialty calculator to see your business priced against the 235 disclosed medical practice specialty transactions in the database. The engine applies adjustments for margin, growth, owner dependency, customer concentration, and recurring revenue mix to produce a tight range around the most-likely transaction value.
More on medical practice specialty valuations
- Value a medical practice specialty· run the calculator
- Who buys medical practice specialty businesses?· active buyers
- Recent deal: Consulting Cardiologists· comparable transaction
- Who acquired Consulting Cardiologists?· buyer profile
- How to value a medical practice specialty· long-form guide
Methodology details: how ExitValue computes valuation ranges · full medical specialty calculator